[Clinical significance of remnant-lipoprotein].
Nakamura
Yuichi
Y
Internal Medicine, Nagaoka Chuo General Hospital.
Miida
Takashi
T
D053299:Apolipoprotein B-100; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B / Q000097:blood / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology; D015415:Biomarkers / Q000097:blood; D001774:Blood Chemical Analysis / Q000379:methods; D001944:Breath Tests; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004224:Diterpenes; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis*; D008074:Lipoproteins / Q000097:blood*; D011973:Receptors, LDL / Q000097:blood / Q000378:metabolism; D000084562:Retinyl Esters; D014280:Triglycerides / Q000097:blood*; D014801:Vitamin A / Q000031:analogs & derivatives* / Q000097:blood
D053299:Apolipoprotein B-100; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B; D015415:Biomarkers; D004224:Diterpenes; D008074:Lipoproteins; D011973:Receptors, LDL; D000084562:Retinyl Esters; D014280:Triglycerides; C036053:VLDL receptor; C112017:remnant-like particle cholesterol; D014801:Vitamin A; C014794:retinol palmitate; D002784:Cholesterol